Secondly, the diagnosis of NAFLD is based on ultrasonography and the severity of NAFLD is divided by serum ALT level, which were non-invasive, convenient and widely used in clinical studies, despite of not being gold standard as live biopsy. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.